China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efgartigimod as an effective and safe option for perioperative treatment in thymoma-associated myasthenia gravis'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135509
Registration Time: 2026/10/30
Type: Observational study
Primary Sponsor: The Second Qilu Hospital of Shandong University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348935
Published by HT Digital Content Services with permission from Health Daily Digest....